On Our Radar Applications open for leadership academy, plus a recap of Warnocks visit - AOL
RAPH Stock | 0.26 0.00 0.00% |
Under 61% of Raphael Pharmaceutical's investor base is looking to short. The analysis of current outlook of investing in Raphael Pharmaceutical suggests that many traders are alarmed regarding Raphael Pharmaceutical's prospects. Raphael Pharmaceutical's investing sentiment shows overall attitude of investors towards Raphael Pharmaceutical.
Raphael |
On Our Radar Applications open for leadership academy, plus a recap of Warnocks visit AOL
Read at news.google.com
Raphael Pharmaceutical Fundamental Analysis
We analyze Raphael Pharmaceutical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Raphael Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Raphael Pharmaceutical based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Asset
Total Asset Comparative Analysis
Raphael Pharmaceutical is currently under evaluation in total asset category among its peers. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Raphael Pharmaceutical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Raphael Pharmaceutical otc stock to make a market-neutral strategy. Peer analysis of Raphael Pharmaceutical could also be used in its relative valuation, which is a method of valuing Raphael Pharmaceutical by comparing valuation metrics with similar companies.
Peers
Raphael Pharmaceutical Related Equities
AMKR | Amkor Technology | 2.42 | ||||
RSVR | Reservoir Media | 1.94 | ||||
PLXS | Plexus Corp | 1.09 | ||||
VLN | Valens | 0.90 | ||||
WB | Weibo Corp | 0.58 | ||||
SONO | Sonos | 0.48 | ||||
KNDI | Kandi Technologies | 2.94 | ||||
PINS | 3.41 |
Complementary Tools for Raphael OTC Stock analysis
When running Raphael Pharmaceutical's price analysis, check to measure Raphael Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Raphael Pharmaceutical is operating at the current time. Most of Raphael Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Raphael Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Raphael Pharmaceutical's price. Additionally, you may evaluate how the addition of Raphael Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |